116094-23-6

Basic information

• Product Name: INSULIN ASPART
• Synonyms: INSULIN ASPART;D04475;Insulin aspart (genetical recombination);Insulin aspart (genetical recombination) (jan);Insulin aspart (usan/inn);Insulin X 14;Novolog;Novolog (tn)
• CAS NO: 116094-23-6
• Molecular Formula: C256H381N65O79S6
• Mol File: 116094-23-6.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Solubility: Practically insoluble in ethanol (96 per cent), in methanol and in aqueous solutions with a pH around 5.1. In aqueous solutions below pH 3.5 or above pH 6.5, the solubility is greater than or equal to 25 mg/mL.
• CAS DataBase Reference: INSULIN ASPART(CAS DataBase Reference)
• NIST Chemistry Reference: INSULIN ASPART(116094-23-6)
• EPA Substance Registry System: INSULIN ASPART(116094-23-6)

Safety Data

• Hazardous Substances Data: 116094-23-6(Hazardous Substances Data)

Usage

Description

Insulin Aspart is a recombinant, biosynthetic, fast-acting insulin analogue that is used to help control blood sugar levels in individuals with type 1 and type 2 diabetes mellitus. It is chemically synthesized and has a single amino acid substitution at position B28, where proline is replaced with aspartic acid. Insulin Aspart is a white or almost white powder.

Uses

Used in Pharmaceutical Industry:
Insulin Aspart is used as a pharmaceutical agent for the treatment of diabetes mellitus. It helps to regulate blood sugar levels by mimicking the action of naturally occurring insulin in the body.
Used in Diabetes Management:
Insulin Aspart is used as a diabetes management tool for individuals with type 1 and type 2 diabetes mellitus. It provides a rapid onset of action and a short duration of activity, making it suitable for controlling postprandial (after-meal) blood glucose levels.
Used in Insulin Therapy:
Insulin Aspart is used as a component of insulin therapy for patients with diabetes who require insulin injections to maintain proper blood sugar levels. It can be used alone or in combination with other types of insulin to create a personalized insulin regimen tailored to the individual's needs.